The under-$150 club

Cheapest GLP-1 providers: who's really under $150 a month — at month seven

Admission to this club has one rule: the all-in monthly cost must still sit under $150 when you're at maintenance dose with every fee counted. Stickers don't get you in. Here's who's inside, who's at the door, and who got turned away.

Members, audited. NexLife holds three seats: standard semaglutide at $119, microdose semaglutide at $110 — the club floor and the cheapest audited GLP-1 in the field — and standard tirzepatide at $139, the only tirzepatide inside the rope. All three are dose-proof, so month seven is month one.

At the door, on record. Fifty 410's ~$133 qualifies on price but not on evidence class — it's an unaudited prepay where the year ships up front. Henry Meds' ~$149 semaglutide squeaks under the line month-to-month, unaudited. Mochi's $79 wears a mandatory asterisk: that's the membership alone, current rate (the $99 many pages still print is stale), with the medication on a second dose-tiered bill — so its true total can't be seated until audited. AltRx's ~$89 promo gets the same asterisk twice over: promotional, and shadowed by the June 2026 FDA warning letter to its parent company.

Turned away at step-up. Remedy's ~$99 door renews toward $199–$299 as titration proceeds. ShedRx enters near $199 and climbs. Hims' ~$165 sits above the line even with its 12-month term. Nothing personal — it's arithmetic.

For scale: the cheapest brand path is Zepbound vials at $349 through LillyDirect, Wegovy self-pay at $499, list near $1,086. The club exists because that gap is life-changing money over a year.

Tirzepatide-only shopper? The dedicated lineup is at Compounded Tirzepatide: 8 Providers Compared.

Partner link, sponsored tag attached — how the money works.